Press Release Tubulis
2023-04-20

Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients

Companies join forces bringing together…
read more
Confo Therapeutics Press Release
2023-03-30

Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases

Collaboration to make use of…
read more
Exevir Press Release
2023-03-13

ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19.

ExeVir Bio and VIB-UGent’s bioRxiv…
read more
Confo Therapeutics Press Release
2023-03-02

Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554

Confo to receive upfront and…
read more
Cellaïon Press Release
2023-01-30

Cellaion SA announces a total fundraising of EUR 23 million in 2022 for its phase IIB study in Acute on Chronic Liver Failure with Truffle Capital as lead investor in the final Closing followed by Newton Biocapital, Wallonie Entreprendre and individual investors.

Mont-Saint-Guibert, Belgium, 2023/01/13. Cellaïon is…
read more
Press Release TargED
2023-01-19

TargED Biopharmaceuticals announces the appointment of Erik van den Berg as Chair of its Supervisory Board

Utrecht, the Netherlands, January 19,…
read more
Exevir Press Release
2023-01-09

Belgium: ExeVir lands European venture debt financing to develop novel nanobody COVID-19 therapy

ExeVir signs €25 million venture debt…
read more
Novadip Press Release
2022-12-27

Novadip Biosciences SA Appoints Judy Ashworth, MD, as Chief Medical Officer

Mont Saint-Guibert, Belgium – December…
read more
Novadip Press Release
2022-12-09

Novadip Biosciences SA Announces Positive Results from Phase 1/2 Clinical Trial in Patients with Severe Bone Non-Union of the Lower Limb Following Trauma

Study results demonstrate NVD-003 has…
read more
Minoryx Press Release
2022-11-10

Minoryx and Neuraxpharm announce a strategic alliance to provide a new therapy for rare CNS disease patients in Europe9

The companies enter into a…
read more